The commonly held hypothesis that antibiotic resistance arises through (over)exposure to antibiotics is questioned in this new research. It weakens the link between resistance and antibiotic use and suggests that “… antibiotic resistance is natural, ancient, and hard wired in the microbial pangenome.” This has implications for how we think about R&D around antibiotics and how […]
Science Technology & Society, Vol. 15, No. 1, 77-111 (2010) Jacques Gaillard This article seeks to present the main characteristics of Research and Development (R&D) in developing countries using mainly available R&D statistics and to draw some implications for the Frascati Manual methodologies and its application. The main characteristics presented include trends and concentrations, relative […]
French multinational pharmaceutical company Sanofi-Aventis on Tuesday opened its first regional research and development center in China, the Shanghai Daily reported. The company expects that the Asia-Pacific R&D center will accelerate the development of therapies and health solutions in the region, said Marc Cluzel, vice president of research and development. Sales in emerging markets such […]
Pfizer has announced to initiate with more research work on Asian populations in coming years in a bid to develop drugs for diseases prevalent in the region, such as cancers of the liver and head and neck. “Prevalence rates for specific types of cancer are significantly higher (in Asia), for example gastric cancer, liver cancer, […]
Australian pharmaceutical firms assert that the proposed legislation will “deter innovation and investment”.
GE is clearly committed to healthcare – big spend in R&D to develop affordable and quality products and services. It will be very interesting to see what they have in their pipeline.